MAXCYTE INC DL-01
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based … Read more
Market Cap & Net Worth: MAXCYTE INC DL-01 (MYE0)
MAXCYTE INC DL-01 (F:MYE0) has a market capitalization of $75.01 Million (€73.07 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #19876 globally and #2121 in its home market, demonstrating a 8.73% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MAXCYTE INC DL-01's stock price €0.69 by its total outstanding shares 106674011 (106.67 Million).
MAXCYTE INC DL-01 Market Cap History: 2021 to 2026
MAXCYTE INC DL-01's market capitalization history from 2021 to 2026. Data shows change from $958.11 Million to $75.01 Million (-36.89% CAGR).
MAXCYTE INC DL-01 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MAXCYTE INC DL-01's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MYE0 by Market Capitalization
Companies near MAXCYTE INC DL-01 in the global market cap rankings as of March 19, 2026.
Key companies related to MAXCYTE INC DL-01 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
MAXCYTE INC DL-01 Historical Marketcap From 2021 to 2026
Between 2021 and today, MAXCYTE INC DL-01's market cap moved from $958.11 Million to $ 75.01 Million, with a yearly change of -36.89%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €75.01 Million | -46.90% |
| 2025 | €141.25 Million | -65.87% |
| 2024 | €413.90 Million | -3.08% |
| 2023 | €427.04 Million | -21.69% |
| 2022 | €545.30 Million | -43.09% |
| 2021 | €958.11 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of MAXCYTE INC DL-01 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $75.01 Million USD |
| MoneyControl | $75.01 Million USD |
| MarketWatch | $75.01 Million USD |
| marketcap.company | $75.01 Million USD |
| Reuters | $75.01 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.